Abstract:AIMTo further investigate the role of human B7 homolog 1 (B7-H1) in the mechanism of persistent hepatitis B virus (HBV) infection.METHODSPeripheral and intra-hepatic B7-H1 expression were compared by ﬂow cytometry and immunochemical staining between two 2 distinct groups, one being chronic HBV tolerance patients (CHB-T) and the other being acute hepatitis B patients (AHB). B7-H1 mRNA expression level was also compared by real time polymerase chain reaction between CHB-T and AHB patients. The location of intra-hepatic B7-H1 and CD40 expression were analyzed by immunofluorescence. The levels of B7-H1 and CD40 expression on cultured myeloid dendritic cells (mDCs) with or without hepatitis B surface antigen (HBsAg) treatment were analyzed dynamically by ﬂow cytometry. Intracellular interferon-γ (IFN-γ) staining and the stimulatory capacity of mDC of cultured mDC with or without HBsAg treatment were also compared by ﬂow cytometry.RESULTSPeripheral B7-H1 expression on mDCs was increased significantly in AHB compared to CHB-T patients (P < 0.05). In the liver tissues from CHB-T patients, B7-H1 positive cells were almost absent despite a persistently elevated serum HBsAg load. In contrast, there were indeed increased B7-H1-positive cells in situ in the liver tissue from AHB. In vitro analysis showed the parallel upregulation of B7-H1 and CD40 on CD11c+ mDCs after the onset of stimulation. Addition of recombinant hepatitis B surface antigen (rHBsAg) significantly decreased CD40 expression (P < 0.05 at 16 h, 20 h and 24 h time points). B7-H1 expression was also inhibited by rHBsAg, and the inhibition rate of CD40 was greater than that of B7-H1. This preferential inhibition of CD40 expression on mDCs by rHBsAg resulted in the dysfunction of mDCs and T cells in the mixed leucocyte reaction (MLR) system. With rHBsAg pretreatment, in a carboxyﬂuorescein diacetate succinimidyl ester (CFSE) labeled MLR system at a ratio of 1:5 responder cell-stimulator cell (R/S), the CFSE(dim) percentage of T cells decreased from 85.1% to 25.4% and decreased from 30.3% to 12.0% at 1:10 R/S. IFN-γ production by CD8+ T cells, in the MLR system, was reduced significantly by HBsAg pretreatment. At ratios of 1:5 R/S, the percentage of IFN-γ and CD8 dual positive T cells decreased from 55.2% ± 5.3% to 15.1% ± 3.1% (P < 0.001), and decreased from 35.0% ± 5.1% to 7.3% ± 2.7% at ratios of 1:10 R/S (P < 0.001).CONCLUSIONB7-H1 is not a signature of immune dysfunction, but an inflammation marker. HBsAg regulate immune response by tipping the balance between B7-H1 and CD40.

B7-H1 Expression is Up-Regulated in Peripheral Blood Cd14+Monocytes of Patients with Chronic Hepatitis B Virus Infection, Which Correlates with Higher Serum Il-10 Levels

Changes of Costimulatory Molecule CD28 on Circulating CD8+ T Cells Correlate with Disease Pathogenesis of Chronic Hepatitis B.

Elevated Expression of Chemokine CXCL13 in Chronic Hepatitis B Patients Links to Immune Control During Antiviral Therapy

Study of Human B7 Homolog 1 Expression in Patients with Hepatitis B Virus Infection

Il-10-Producing Regulatory B-Cells Suppressed Effector T-Cells but Enhanced Regulatory T-Cells in Chronic Hbv Infection

Characteristics of Regulatory B Cells and Serum IL-10, IP-10 in Different Immune Phases of Chronic Hepatitis B Virus Infection

IL-10-producing regulatory B cells in the pathogenesis of chronic hepatitis B virus infection.

Changes of the peripheral Thelper cell cytokines of patients with chronic hepatitis B during antiviral treatment

Interleukin-7 in Patients with Chronic Hepatitis B May Have Effect on T Follicular Helper Cells and Specific Cellular Immunity.

Circulating Cd4(+)Cd25(High) Regulatory T Cells And Expression Of Pd-1 And Btla On Cd4(+) T Cells In Patients With Chronic Hepatitis B Virus Infection

Regulatory T Cells And Il-17(+) T Helper Cells Enhanced In Patients With Chronic Hepatitis B Virus Infection

HBcAg Induces Interleukin‐10 Production, Inhibiting HBcAg‐specific Th17 Responses in Chronic Hepatitis B Patients

Elevated IL-6 Receptor Expression on CD4+ T Cells Contributes to the Increased Th17 Responses in Patients with Chronic Hepatitis B

Relationship between concentration of IL-7 and cellular immunity in peripheral blood of the patients with chronic hepatitis B

Regulatory Role of CD4 + CD25 + Foxp3 + Regulatory T Cells on IL-17-Secreting T Cells in Chronic Hepatitis B Patients

Circulating Cd4(+) Cd25(+) Regulatory T Cells Correlate With Chronic Hepatitis B Infection

Expression profiles of circulating cytokines, chemokines and immune cells in patients with hepatitis B virus infection

Implication of Th17 and Th1 Cells in Patients with Chronic Active Hepatitis B

Decrease of CD69 levels on TCR Vα7.2+CD4+ innate-like lymphocytes is associated with impaired cytotoxic functions in chronic hepatitis B virus-infected patients

Expression of MicroRNA-155 is Downregulated in Peripheral Blood Mononuclear Cells of Chronic Hepatitis B Patients.

PD-1 Upregulation is Associated with HBV-specific T Cell Dysfunction in Chronic Hepatitis B Patients.